Global Gastrointestinal Stromal Tumor (GIST) Drug Market Insight and Forecast to 2029

The Gastrointestinal Stromal Tumor (GIST) Drug Market has been growing at a faster pace with significant growth rates during the last few years and is anticipated to grow significantly in the forecast period from 2022 to 2029.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Gastrointestinal Stromal Tumor Gist Drug Market

By Market Players:
Ariad Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Astex Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Calithera Biosciences, Inc.
Array BioPharma Inc.
F. Hoffmann-La Roche Ltd.
Boston Biomedical, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Natco Pharma Limited
Omeros Corporation
Horizon Pharma Plc
Nerviano Medical Sciences S.r.l.
Kolltan Pharmaceuticals, Inc.
Immunicum AB
Novartis AG
Jiangsu Hengrui Medicine Co., Ltd.

By Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

By Application
Clinic
Hospital
Others

By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2021, and development forecast 2022-2029 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2021.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2018-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2029. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Gastrointestinal Stromal Tumor Gist Drug Market
Market Analysis by Product Type: The report covers majority Product Types in the Gastrointestinal Stromal Tumor (GIST) Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gastrointestinal Stromal Tumor (GIST) Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal Stromal Tumor (GIST) Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type: 2022 VS 2029
1.4.2 Amcasertib
1.4.3 Anagrelide hydrochloride CR
1.4.4 APG-1351
1.4.5 Binimetinib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2022-2029
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Perspective (2022-2029)
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Regions: 2015 VS 2022 VS 2029
2.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Regions (2018-2021)
2.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Regions (2022-2029)
3 Market Competition by Manufacturers
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Market Share by Manufacturers (2018-2021)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2018-2021)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2018-2021)
4 Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
4.1 North America
4.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in North America (2018-2021)
4.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.1.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.2 East Asia
4.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in East Asia (2018-2021)
4.2.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.3 Europe
4.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Europe (2018-2021)
4.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.4 South Asia
4.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South Asia (2018-2021)
4.4.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.5 Southeast Asia
4.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Southeast Asia (2018-2021)
4.5.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.5.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.6 Middle East
4.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Middle East (2018-2021)
4.6.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.6.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.7 Africa
4.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Africa (2018-2021)
4.7.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.7.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.8 Oceania
4.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Oceania (2018-2021)
4.8.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.8.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.9 South America
4.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South America (2018-2021)
4.9.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.9.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.10 Rest of the World
4.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Rest of the World (2018-2021)
4.10.3 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.10.4 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
5 Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region
5.1 North America
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.10.2 Kazakhstan
6 Gastrointestinal Stromal Tumor (GIST) Drug Sales Market by Type (2018-2029)
6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Type (2018-2021)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2022-2029)
7 Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market by Application(2018-2029)
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Application (2018-2021)
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2022-2029)
8 Company Profiles and Key Figures in Gastrointestinal Stromal Tumor (GIST) Drug Business
8.1 Ariad Pharmaceuticals, Inc.
8.1.1 Ariad Pharmaceuticals, Inc. Company Profile
8.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.2 Chipscreen Biosciences Ltd
8.2.1 Chipscreen Biosciences Ltd Company Profile
8.2.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.2.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.3 Astex Pharmaceuticals, Inc.
8.3.1 Astex Pharmaceuticals, Inc. Company Profile
8.3.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.3.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.4 Arog Pharmaceuticals, Inc.
8.4.1 Arog Pharmaceuticals, Inc. Company Profile
8.4.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.4.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.5 Calithera Biosciences, Inc.
8.5.1 Calithera Biosciences, Inc. Company Profile
8.5.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.5.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.6 Array BioPharma Inc.
8.6.1 Array BioPharma Inc. Company Profile
8.6.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.6.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 F. Hoffmann-La Roche Ltd. Company Profile
8.7.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.7.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.8 Boston Biomedical, Inc.
8.8.1 Boston Biomedical, Inc. Company Profile
8.8.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.8.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.9 Blueprint Medicines Corporation
8.9.1 Blueprint Medicines Corporation Company Profile
8.9.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.9.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.10 Deciphera Pharmaceuticals, LLC
8.10.1 Deciphera Pharmaceuticals, LLC Company Profile
8.10.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.11 Natco Pharma Limited
8.11.1 Natco Pharma Limited Company Profile
8.11.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.11.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.12 Omeros Corporation
8.12.1 Omeros Corporation Company Profile
8.12.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.12.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.13 Horizon Pharma Plc
8.13.1 Horizon Pharma Plc Company Profile
8.13.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.13.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.14 Nerviano Medical Sciences S.r.l.
8.14.1 Nerviano Medical Sciences S.r.l. Company Profile
8.14.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.14.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.15 Kolltan Pharmaceuticals, Inc.
8.15.1 Kolltan Pharmaceuticals, Inc. Company Profile
8.15.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.15.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.16 Immunicum AB
8.16.1 Immunicum AB Company Profile
8.16.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.16.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.17 Novartis AG
8.17.1 Novartis AG Company Profile
8.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.18 Jiangsu Hengrui Medicine Co., Ltd.
8.18.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
8.18.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.18.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug (2022-2029)
9.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug (2022-2029)
9.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug (2018-2029)
9.4 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2022-2029)
9.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.6 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.7 Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.8 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.10 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.5 Forecast by Type and by Application (2022-2029)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2029)
9.5.2 Global Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2022-2029)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.2 East Asia Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.3 Europe Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Countriy
10.4 South Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.5 Southeast Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.6 Middle East Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.7 Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.8 Oceania Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.9 South America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.10 Rest of the world Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
12 Industry Trends and Growth Strategy
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Growth Strategy
13 Analyst’s Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer

Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type: 2022 VS 2029
Table 2. Amcasertib Features
Table 3. Anagrelide hydrochloride CR Features
Table 4. APG-1351 Features
Table 5. Binimetinib Features
Table 6. Others Features
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2022 VS 2029
Table 12. Clinic Case Studies
Table 13. Hospital Case Studies
Table 14. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2022-2029 (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Regions: 2021 VS 2026
Table 31. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 32. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 33. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 34. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 35. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 37. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 38. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 39. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 40. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 42. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 43. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2018-2021)
Table 44. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 45. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 46. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 47. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 48. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 50. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 51. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 52. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 53. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 54. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 55. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 56. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 57. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 58. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 59. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 60. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 61. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 62. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 63. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 64. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 65. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 66. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 67. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 68. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 101. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Forecast by Region (2022-2029)
Table 102. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Forecast by Type (2022-2029)
Table 103. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Market Share Forecast by Type (2022-2029)
Table 104. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Forecast by Type (2022-2029)
Table 105. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Market Share Forecast by Type (2022-2029)
Table 106. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Forecast by Type (2022-2029)
Table 107. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2022-2029)
Table 108. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Forecast by Application (2022-2029)
Table 109. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 110. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 111. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 112. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 113. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 114. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 115. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 116. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 117. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 118. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 119. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 120. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table 121. Porter’s Five Forces Analysis
Table 122. Key Executives Interviewed

Figure 1. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 2. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 3. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 4. Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 5. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 6. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 7. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 8. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 9. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 10. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 11. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 12. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region in 2021
Figure 13. Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 14. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 15. France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 16. Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 17. Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 18. Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 19. Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 20. Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 21. Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 22. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 23. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 24. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 25. Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 26. Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 27. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 28. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 29. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 30. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 31. Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 32. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 33. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 34. Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 35. Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 37. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 38. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 39. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 40. Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 41. United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 42. Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 43. Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 44. Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 45. Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 46. Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 47. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 48. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 49. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 50. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 51. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 52. Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 53. Morocco Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 54. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 55. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 56. Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 57. New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 58. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 59. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 60. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 61. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 62. Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 63. Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 64. Venezuelal Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 65. Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 66. Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 67. Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 68. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 69. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 70. Kazakhstan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 71. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Growth Rate Forecast (2022-2029)
Figure 72. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 73. Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2018-2029)
Figure 74. North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 75. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 76. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 77. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 78. Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 79. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 80. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 81. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 82. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 83. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 84. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 85. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 86. Africa Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 87. Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 88. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 89. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 90. South America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 91. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 92. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 93. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 94. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 95. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 96. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 97. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 98. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 99. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 100. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 101. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 102. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 103. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles

 

The Gastrointestinal Stromal Tumor (GIST) Drug Market has been growing at a faster pace with significant growth rates during the last few years and is anticipated to grow significantly in the forecast period from 2022 to 2029.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

Gastrointestinal Stromal Tumor Gist Drug Market

By Market Players:
Ariad Pharmaceuticals, Inc.
Chipscreen Biosciences Ltd
Astex Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Calithera Biosciences, Inc.
Array BioPharma Inc.
F. Hoffmann-La Roche Ltd.
Boston Biomedical, Inc.
Blueprint Medicines Corporation
Deciphera Pharmaceuticals, LLC
Natco Pharma Limited
Omeros Corporation
Horizon Pharma Plc
Nerviano Medical Sciences S.r.l.
Kolltan Pharmaceuticals, Inc.
Immunicum AB
Novartis AG
Jiangsu Hengrui Medicine Co., Ltd.

By Type
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others

By Application
Clinic
Hospital
Others

By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Gastrointestinal Stromal Tumor (GIST) Drug 2018-2021, and development forecast 2022-2029 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2021.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2018-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2029. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Gastrointestinal Stromal Tumor Gist Drug Market
Market Analysis by Product Type: The report covers majority Product Types in the Gastrointestinal Stromal Tumor (GIST) Drug Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Gastrointestinal Stromal Tumor (GIST) Drug Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gastrointestinal Stromal Tumor (GIST) Drug market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor (GIST) Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate by Type: 2022 VS 2029
1.4.2 Amcasertib
1.4.3 Anagrelide hydrochloride CR
1.4.4 APG-1351
1.4.5 Binimetinib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2022-2029
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Perspective (2022-2029)
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Regions: 2015 VS 2022 VS 2029
2.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Regions (2018-2021)
2.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Regions (2022-2029)
3 Market Competition by Manufacturers
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Market Share by Manufacturers (2018-2021)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2018-2021)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2018-2021)
4 Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
4.1 North America
4.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in North America (2018-2021)
4.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.1.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.2 East Asia
4.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in East Asia (2018-2021)
4.2.3 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.2.4 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.3 Europe
4.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Europe (2018-2021)
4.3.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.3.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.4 South Asia
4.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South Asia (2018-2021)
4.4.3 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.5 Southeast Asia
4.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Southeast Asia (2018-2021)
4.5.3 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.5.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.6 Middle East
4.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Middle East (2018-2021)
4.6.3 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.6.4 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.7 Africa
4.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Africa (2018-2021)
4.7.3 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.7.4 Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.8 Oceania
4.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Oceania (2018-2021)
4.8.3 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.8.4 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.9 South America
4.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in South America (2018-2021)
4.9.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.9.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
4.10 Rest of the World
4.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2018-2029)
4.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Players in Rest of the World (2018-2021)
4.10.3 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (2018-2021)
4.10.4 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application (2018-2021)
5 Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region
5.1 North America
5.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries
5.10.2 Kazakhstan
6 Gastrointestinal Stromal Tumor (GIST) Drug Sales Market by Type (2018-2029)
6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Type (2018-2021)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2022-2029)
7 Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market by Application(2018-2029)
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Application (2018-2021)
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2022-2029)
8 Company Profiles and Key Figures in Gastrointestinal Stromal Tumor (GIST) Drug Business
8.1 Ariad Pharmaceuticals, Inc.
8.1.1 Ariad Pharmaceuticals, Inc. Company Profile
8.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.2 Chipscreen Biosciences Ltd
8.2.1 Chipscreen Biosciences Ltd Company Profile
8.2.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.2.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.3 Astex Pharmaceuticals, Inc.
8.3.1 Astex Pharmaceuticals, Inc. Company Profile
8.3.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.3.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.4 Arog Pharmaceuticals, Inc.
8.4.1 Arog Pharmaceuticals, Inc. Company Profile
8.4.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.4.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.5 Calithera Biosciences, Inc.
8.5.1 Calithera Biosciences, Inc. Company Profile
8.5.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.5.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.6 Array BioPharma Inc.
8.6.1 Array BioPharma Inc. Company Profile
8.6.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.6.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.7 F. Hoffmann-La Roche Ltd.
8.7.1 F. Hoffmann-La Roche Ltd. Company Profile
8.7.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.7.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.8 Boston Biomedical, Inc.
8.8.1 Boston Biomedical, Inc. Company Profile
8.8.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.8.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.9 Blueprint Medicines Corporation
8.9.1 Blueprint Medicines Corporation Company Profile
8.9.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.9.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.10 Deciphera Pharmaceuticals, LLC
8.10.1 Deciphera Pharmaceuticals, LLC Company Profile
8.10.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.11 Natco Pharma Limited
8.11.1 Natco Pharma Limited Company Profile
8.11.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.11.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.12 Omeros Corporation
8.12.1 Omeros Corporation Company Profile
8.12.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.12.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.13 Horizon Pharma Plc
8.13.1 Horizon Pharma Plc Company Profile
8.13.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.13.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.14 Nerviano Medical Sciences S.r.l.
8.14.1 Nerviano Medical Sciences S.r.l. Company Profile
8.14.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.14.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.15 Kolltan Pharmaceuticals, Inc.
8.15.1 Kolltan Pharmaceuticals, Inc. Company Profile
8.15.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.15.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.16 Immunicum AB
8.16.1 Immunicum AB Company Profile
8.16.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.16.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.17 Novartis AG
8.17.1 Novartis AG Company Profile
8.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
8.18 Jiangsu Hengrui Medicine Co., Ltd.
8.18.1 Jiangsu Hengrui Medicine Co., Ltd. Company Profile
8.18.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
8.18.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Revenue, Price and Gross Margin (2018-2021)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug (2022-2029)
9.2 Global Forecasted Revenue of Gastrointestinal Stromal Tumor (GIST) Drug (2022-2029)
9.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug (2018-2029)
9.4 Global Forecasted Production of Gastrointestinal Stromal Tumor (GIST) Drug by Region (2022-2029)
9.4.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.2 East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.4 South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.6 Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.7 Africa Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.8 Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.9 South America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.4.10 Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue Forecast (2022-2029)
9.5 Forecast by Type and by Application (2022-2029)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2029)
9.5.2 Global Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2022-2029)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.2 East Asia Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.3 Europe Market Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Countriy
10.4 South Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.5 Southeast Asia Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.6 Middle East Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.7 Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.8 Oceania Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.9 South America Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
10.10 Rest of the world Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
12 Industry Trends and Growth Strategy
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Growth Strategy
13 Analyst’s Viewpoints/Conclusions
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer

Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type: 2022 VS 2029
Table 2. Amcasertib Features
Table 3. Anagrelide hydrochloride CR Features
Table 4. APG-1351 Features
Table 5. Binimetinib Features
Table 6. Others Features
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application: 2022 VS 2029
Table 12. Clinic Case Studies
Table 13. Hospital Case Studies
Table 14. Others Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2022-2029 (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Regions: 2021 VS 2026
Table 31. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 32. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 33. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 34. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 35. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 37. Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 38. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 39. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 40. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth (2018-2029) (US$ Million)
Table 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 42. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 43. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2018-2021)
Table 44. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 45. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 46. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 47. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 48. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 50. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Countries (2018-2021)
Table 51. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 52. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 53. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 54. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 55. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 56. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 57. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 58. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 59. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 60. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 61. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 62. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 63. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 64. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 65. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 66. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 67. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 68. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Specification
Table 101. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Forecast by Region (2022-2029)
Table 102. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Forecast by Type (2022-2029)
Table 103. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Volume Market Share Forecast by Type (2022-2029)
Table 104. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Forecast by Type (2022-2029)
Table 105. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue Market Share Forecast by Type (2022-2029)
Table 106. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price Forecast by Type (2022-2029)
Table 107. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Volume Forecast by Application (2022-2029)
Table 108. Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Value Forecast by Application (2022-2029)
Table 109. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 110. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 111. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 112. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 113. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 114. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 115. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 116. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 117. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 118. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029 by Country
Table 119. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 120. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table 121. Porter’s Five Forces Analysis
Table 122. Key Executives Interviewed

Figure 1. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 2. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 3. United States Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 4. Canada Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 5. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 6. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 7. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 8. China Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 9. Japan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 10. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 11. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 12. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Region in 2021
Figure 13. Germany Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 14. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 15. France Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 16. Italy Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 17. Russia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 18. Spain Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 19. Netherlands Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 20. Switzerland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 21. Poland Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 22. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 23. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 24. India Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 25. Pakistan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 26. Bangladesh Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 27. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 28. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 29. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 30. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 31. Singapore Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 32. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 33. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 34. Vietnam Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 35. Myanmar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 36. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 37. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 38. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 39. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 40. Iran Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 41. United Arab Emirates Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 42. Israel Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 43. Iraq Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 44. Qatar Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 45. Kuwait Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 46. Oman Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 47. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 48. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 49. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 50. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 51. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 52. Algeria Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 53. Morocco Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 54. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 55. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 56. Australia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 57. New Zealand Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 58. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 59. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 60. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 61. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 62. Columbia Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 63. Chile Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 64. Venezuelal Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 65. Peru Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 66. Puerto Rico Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 67. Ecuador Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 68. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate
Figure 69. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Countries in 2021
Figure 70. Kazakhstan Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Growth Rate (2018-2021)
Figure 71. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Growth Rate Forecast (2022-2029)
Figure 72. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 73. Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2018-2029)
Figure 74. North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 75. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 76. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 77. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 78. Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 79. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 80. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 81. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 82. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 83. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 84. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 85. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 86. Africa Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 87. Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 88. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 89. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 90. South America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 91. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 92. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast (2022-2029)
Figure 93. Rest of the World Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast (2022-2029)
Figure 94. North America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 95. East Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 96. Europe Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 97. South Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 98. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 99. Middle East Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 100. Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 101. Oceania Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 102. South America Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 103. Rest of the world Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast 2022-2029
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles

 

Frequently Asked Questions About This Report

Choose License Type

single-user
$2,350
multi-user
$3,525
enterprise-user
$4,700

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.